Aster DM Quality Care reports ₹2,829 crore Q2 revenue

Aster DM Quality Care Limited reported consolidated revenue from operations of ₹2,829.20 crore for the quarter ended September 30, 2026, after the July 1 amalgamation with Quality Care India Limited. The board approved unaudited standalone and consolidated Q2 and half-year FY27 results on November 6, following review by its Audit Committee and statutory auditor Deloitte Haskins & Sells.

What did Aster DM Quality Care report for Q2 FY27?

Aster DM Quality Care reported consolidated revenue from operations of ₹2,829.20 crore and total income of ₹2,880.73 crore for the September 2026 quarter. Consolidated total expenses were ₹2,434.43 crore, resulting in profit before tax of ₹419.35 crore for the quarter.

On a standalone basis, revenue from operations stood at ₹1,204.21 crore in Q2 FY27, while total income was ₹1,250.33 crore. Standalone total expenses were ₹1,124.18 crore and profit before tax was ₹111.92 crore. The results are unaudited and cover the three months ended September 30, 2026.

The reported figures are significant because they provide the first published Q2 financial update after Quality Care India Limited was amalgamated into the company. The merger became effective on July 1, 2026, and Aster DM Quality Care was formerly known as Aster DM Healthcare Limited.

How did Aster DM Quality Care perform in the first half of FY27?

Aster DM Quality Care recorded consolidated revenue from operations of ₹4,139.88 crore for the six months ended September 30, 2026, with profit before tax of ₹497.43 crore. Consolidated total income for the half year was ₹4,228.44 crore, while total expenses were ₹3,731.01 crore.

The standalone business reported revenue from operations of ₹1,929.94 crore and total income of ₹2,015.09 crore for H1 FY27. Its standalone profit before tax was ₹122.81 crore. These figures cover the six-month period ending September 30 and are separate from the consolidated statements, which include the group-level financial position.

The standalone and consolidated figures should not be treated as interchangeable. The standalone statements reflect the legal entity, while the consolidated statements present financial information for the group and are particularly relevant following the amalgamation.

Why does the Quality Care India merger matter for these results?

The Quality Care India merger matters because it changed the corporate structure and scale reflected in Aster DM Quality Care's financial reporting. The Scheme of Amalgamation took effect on July 1, 2026, under which Quality Care India Limited merged with Aster DM Healthcare Limited, which was subsequently renamed Aster DM Quality Care Limited.

As a result, the September quarter falls after the effective merger date. Readers assessing the reported numbers need to recognise that the financial statements carry the impact of the scheme. The company has specifically identified the amalgamation as relevant to the Q2 and H1 FY27 results.

The company had earlier informed the exchanges on October 28 that its board would meet on November 6 to consider the unaudited standalone and consolidated results for the quarter and half year ended September 30. The board approval followed that prior intimation process under listing regulations.

The results were reviewed by the Audit Committee and by Deloitte Haskins & Sells, the statutory auditors. Aster DM Quality Care said the financial statements would be published in newspapers in line with the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and made available on its website.

What should investors take from the Q2 FY27 disclosures?

Investors should take the consolidated revenue, expense and pre-tax profit figures as the principal reported financial markers for the September quarter. Revenue from operations of ₹2,829.20 crore, total expenses of ₹2,434.43 crore and profit before tax of ₹419.35 crore set out the scale of the consolidated business in the reported period.

The filings do not provide an estimated outlook or a profit forecast for future quarters. They do, however, provide a formal financial record of the quarter after the merger's July 1 effective date. Any comparison with earlier periods requires care because the company has undergone an amalgamation and a subsequent name change.

Aster DM Quality Care also announced an earnings conference call for November 6 at 6:00 PM IST to discuss the Q2 and H1 FY27 results. The call was to include the Executive Chairman, Managing Director and Group Chief Executive Officer, Executive Director, and Group Chief Financial Officer.

For shareholders and market participants, the management discussion is relevant to understanding how the company explains the reported standalone and consolidated performance. The disclosed results themselves establish the reported revenue and pre-tax profit, while commentary from the call may provide further context on operations following the amalgamation.

Conclusion

Aster DM Quality Care's Q2 FY27 disclosure reports consolidated revenue from operations of ₹2,829.20 crore and profit before tax of ₹419.35 crore, alongside standalone revenue of ₹1,204.21 crore. The results are the company's formal financial update for the September quarter after Quality Care India became part of the combined entity from July 1, 2026.

The next disclosed point for investors to monitor is management's discussion of the Q2 and H1 FY27 numbers at the earnings conference call scheduled for 6:00 PM IST on November 6. The company has also said the unaudited results will be published in newspapers and remain available on its official website in accordance with listing requirements.